维拉科技

最新新闻

• William Blair Maintains Veracyte(VCYT.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/16
• 评级变动
  Needham Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $48
  \u5e02\u573a\u8d44\u8baf · 2026/5/28
• 评级变动
  Piper Sandler Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $66
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• UBS Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $65
  \u5e02\u573a\u8d44\u8baf · 2026/9/9
• 评级变动
  Jefferies Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $70
  \u5e02\u573a\u8d44\u8baf · 2026/7/9
• 评级变动
  Guggenheim Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $65
  \u5e02\u573a\u8d44\u8baf · 2026/6/29
• 评级变动
  Needham Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $57
  \u5e02\u573a\u8d44\u8baf · 2026/6/1
• Piper Sandler Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $54
  \u5e02\u573a\u8d44\u8baf · 2026/9/17
• 评级变动
  Piper Sandler Initiates Veracyte(VCYT.US) With Buy Rating, Announces Target Price $66
  \u5e02\u573a\u8d44\u8baf · 2026/7/15
• 评级变动
  CCORF Maintains Veracyte(VCYT.US) With Hold Rating, Raises Target Price to $60
  \u5e02\u573a\u8d44\u8baf · 2026/7/14
• 评级变动
  Needham Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $69
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  William Blair Initiates Veracyte(VCYT.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  CCORF Maintains Veracyte(VCYT.US) With Hold Rating, Cuts Target Price to $50
  \u5e02\u573a\u8d44\u8baf · 2026/8/3
• 评级变动
  Needham Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $69
  \u5e02\u573a\u8d44\u8baf · 2026/9/15
• Craig-Hallum Maintains Veracyte(VCYT.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/16
• Freedom Capital Markets Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $66
  \u5e02\u573a\u8d44\u8baf · 2026/9/15
• 评级变动
  Morgan Stanley Maintains Veracyte(VCYT.US) With Sell Rating, Cuts Target Price to $44
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• 评级变动
  Piper Sandler Maintains Veracyte(VCYT.US) With Buy Rating, Cuts Target Price to $54
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• 评级变动
  Stephens Initiates Veracyte(VCYT.US) With Buy Rating, Announces Target Price $55
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• 评级变动
  Morgan Stanley Maintains Veracyte(VCYT.US) With Sell Rating, Raises Target Price to $47
  \u5e02\u573a\u8d44\u8baf · 2026/7/9

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。